Matches in SemOpenAlex for { <https://semopenalex.org/work/W2975348229> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2975348229 abstract "1010 Background: In TNBC initial response to chemotherapy is often favorable, but relapse and chemotherapy resistance frequently occur in advanced disease. Hence there is an urgent need for targeted treatments in this breast cancer subtype. Methods: To identify biomarkers of chemotherapy resistance and putative directed treatment targets, we performed next generation sequencing (NGS) of 2,000 genes implicated in oncogenesis. DNA from 31 pre-treatment biopsies and matched normal blood was sequenced. Biopsies were derived from patients scheduled to receive neoadjuvant chemotherapy with doxorubicin/cyclophosphamide. For the analysis, the tumors were divided in responders and non-responders, depending on whether or not a pathological complete remission (pCR) was achieved. Two definitions of pCR were employed: either the complete absence of infiltrating tumor cells in the breast (n=18) or a pCR of both the breast and lymph nodes (n=15). Tumors with partial or no responses were grouped in the non-responder category. Results: As a positive control, we verified that all patients with a known germline BRCA1 mutation (n=8) could be detected by the NGS analysis. In further analyses, we focused only on somatic mutations. Overall, the mutation rate was slightly higher in the non-responders (per tumor, average=12, range=[3-25]) than in the responders (average=8, range=[3-19]) (p=0.17). The analysis of individual genes did not reveal significant differences between responders and non-responders. However, pathway analysis showed that mutations in phosphatidylinositol signaling (e.g., PIK3CA, CALML5) were significantly more frequent in the non-responders, with mutations present in 10/13 non-responders and 2/18 responders (adjusted p=0.013). The chemokine and integrin signaling pathways also revealed a significantly higher mutation rate in the non-responders. Conclusions: Mutations in genes of the phosphatidylinositol pathway occur frequently in TNBCs that do not achieve a pCR on a neoadjuvant chemotherapy regimen consisting of doxorubicin and cyclophosphamide. After validation, alternative chemotherapy regimens and targeted agents should be investigated for these tumors." @default.
- W2975348229 created "2019-10-03" @default.
- W2975348229 creator A5014964963 @default.
- W2975348229 creator A5020129085 @default.
- W2975348229 creator A5020517461 @default.
- W2975348229 creator A5023811426 @default.
- W2975348229 creator A5050409251 @default.
- W2975348229 creator A5054596171 @default.
- W2975348229 creator A5054843849 @default.
- W2975348229 creator A5060207753 @default.
- W2975348229 creator A5070619938 @default.
- W2975348229 creator A5076006564 @default.
- W2975348229 creator A5090670668 @default.
- W2975348229 date "2013-05-20" @default.
- W2975348229 modified "2023-10-01" @default.
- W2975348229 title "Next-generation sequencing to find predictors for chemotherapy response in triple-negative breast cancer (TNBC)." @default.
- W2975348229 doi "https://doi.org/10.1200/jco.2013.31.15_suppl.1010" @default.
- W2975348229 hasPublicationYear "2013" @default.
- W2975348229 type Work @default.
- W2975348229 sameAs 2975348229 @default.
- W2975348229 citedByCount "0" @default.
- W2975348229 crossrefType "journal-article" @default.
- W2975348229 hasAuthorship W2975348229A5014964963 @default.
- W2975348229 hasAuthorship W2975348229A5020129085 @default.
- W2975348229 hasAuthorship W2975348229A5020517461 @default.
- W2975348229 hasAuthorship W2975348229A5023811426 @default.
- W2975348229 hasAuthorship W2975348229A5050409251 @default.
- W2975348229 hasAuthorship W2975348229A5054596171 @default.
- W2975348229 hasAuthorship W2975348229A5054843849 @default.
- W2975348229 hasAuthorship W2975348229A5060207753 @default.
- W2975348229 hasAuthorship W2975348229A5070619938 @default.
- W2975348229 hasAuthorship W2975348229A5076006564 @default.
- W2975348229 hasAuthorship W2975348229A5090670668 @default.
- W2975348229 hasConcept C121608353 @default.
- W2975348229 hasConcept C126322002 @default.
- W2975348229 hasConcept C143998085 @default.
- W2975348229 hasConcept C2776694085 @default.
- W2975348229 hasConcept C2780110267 @default.
- W2975348229 hasConcept C2992734768 @default.
- W2975348229 hasConcept C530470458 @default.
- W2975348229 hasConcept C71924100 @default.
- W2975348229 hasConceptScore W2975348229C121608353 @default.
- W2975348229 hasConceptScore W2975348229C126322002 @default.
- W2975348229 hasConceptScore W2975348229C143998085 @default.
- W2975348229 hasConceptScore W2975348229C2776694085 @default.
- W2975348229 hasConceptScore W2975348229C2780110267 @default.
- W2975348229 hasConceptScore W2975348229C2992734768 @default.
- W2975348229 hasConceptScore W2975348229C530470458 @default.
- W2975348229 hasConceptScore W2975348229C71924100 @default.
- W2975348229 hasLocation W29753482291 @default.
- W2975348229 hasOpenAccess W2975348229 @default.
- W2975348229 hasPrimaryLocation W29753482291 @default.
- W2975348229 hasRelatedWork W188512796 @default.
- W2975348229 hasRelatedWork W1974081174 @default.
- W2975348229 hasRelatedWork W1981536714 @default.
- W2975348229 hasRelatedWork W2030888866 @default.
- W2975348229 hasRelatedWork W2077253803 @default.
- W2975348229 hasRelatedWork W2086532101 @default.
- W2975348229 hasRelatedWork W2090099783 @default.
- W2975348229 hasRelatedWork W2168461608 @default.
- W2975348229 hasRelatedWork W2367105124 @default.
- W2975348229 hasRelatedWork W2534174115 @default.
- W2975348229 hasRelatedWork W2559855573 @default.
- W2975348229 hasRelatedWork W2559949303 @default.
- W2975348229 hasRelatedWork W2584184160 @default.
- W2975348229 hasRelatedWork W2586986791 @default.
- W2975348229 hasRelatedWork W2604136446 @default.
- W2975348229 hasRelatedWork W2945665275 @default.
- W2975348229 hasRelatedWork W3011208491 @default.
- W2975348229 hasRelatedWork W3021255378 @default.
- W2975348229 hasRelatedWork W3029013680 @default.
- W2975348229 hasRelatedWork W3164195368 @default.
- W2975348229 isParatext "false" @default.
- W2975348229 isRetracted "false" @default.
- W2975348229 magId "2975348229" @default.
- W2975348229 workType "article" @default.